Clinical Trial Update: Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fexuprazan to esomeprazole in patients with gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Fexuprazan (fexuprazan)

Snippet

Sponsor: Indonesia University | Conditions: Gastro Oesophageal Reflux Disease | Phase 3 | Status: COMPLETED